 PRINCETON, N.J., Aug. 25, 2022 GLOBE NEWSWIRE -- Oyster Point Pharma, Inc. Nasdaq: OYST, a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced the presentation of analyses at the Women in Ophthalmology WIO Summer Symposium, which is taking place in Monterey, California from August 25-28, 2022. 